CARELONRX, Inc. entered into a definitive agreement to acquire Specialty pharmacy business of The Kroger Co. (NYSE:KR) for approximately $490 million on March 18, 2024. The transaction is subject to customary closing conditions, including regulatory approvals and is expected to close in the second half of 2024.

RBC Capital Markets, LLC is acting as financial advisor, Weil, Gotshal & Manges LLP and Arnold & Porter Kaye Scholer LLP are acting as legal advisors to The Kroger Co.